Quantiphi Strengthens AI Drug Discovery, Development Collaboration with Transcell Through Strategic Minority Investment

Full Article
Quantiphi Strengthens AI Drug Discovery, Development Collaboration with Transcell Through Strategic Minority Investment

Quantiphi has made a strategic minority investment in Transcell, a leading biotech innovator. This collaboration aims to enhance AI-supported drug discovery and development processes in the life sciences sector. The partnership focuses on reducing animal testing and accelerating preclinical decisions for biotherapeutics and vaccines.

The integration of AI and stem cell technology is expected to improve treatment outcomes and elevate industry standards. Both companies are committed to ethical AI practices, which will facilitate automated bioassay implementation. This investment aligns with Quantiphi's ongoing strategy to enhance customer value through innovative partnerships.

• Quantiphi's investment enhances AI-driven drug discovery and development.

• Collaboration aims to reduce animal testing in pharmaceutical research.

Key AI Terms Mentioned in this Article

AI-supported drug discovery

This approach aims to streamline research and development, making it more efficient and effective.

Ethical AI

The partnership emphasizes ethical AI to support automated bioassay implementation.

Automated bioassay

This technology is crucial for accelerating decision-making processes in drug development.

Companies Mentioned in this Article

Quantiphi

Quantiphi's investment in Transcell reflects its commitment to advancing AI in healthcare.

Transcell

Transcell aims to improve treatment outcomes through innovative, animal-free testing strategies.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics